Dermatological Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications), by Drug Class (Anti-infectives, Cort

Dermatological Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028


The Global Disposable Medical Sensors Market has reached a value of USD 8.01 billion in 2022 and is poised for robust growth, with an expected Compound Annual Growth Rate (CAGR) of 7.98% through 2028. This market is undergoing significant expansion and innovation, fundamentally reshaping the landscape of healthcare technology. Disposable medical sensors have emerged as critical components in modern healthcare, enabling precise monitoring, diagnostics, and patient care. The market is characterized by a consistent increase in demand, driven by factors such as an aging population, the rising incidence of chronic diseases, and a growing focus on preventive healthcare.

Disposable medical sensors are specialized devices designed for single-use applications, offering advantages in terms of hygiene, convenience, and cost-effectiveness. They find extensive applications across various medical fields, from continuous patient monitoring to point-of-care testing. The market encompasses a wide range of sensor types, including those used for monitoring vital signs (e.g., heart rate, blood pressure, and oxygen saturation), glucose monitoring, pregnancy testing, and more. These sensors are integrated into various medical devices, including wearable fitness trackers, glucose meters, and diagnostic test strips.

Disposable medical sensors have revolutionized the healthcare industry by providing a cost-effective and efficient means of monitoring patients' vital signs, diagnosing medical conditions, and enhancing overall patient care. These compact, portable devices have become indispensable tools for healthcare professionals in various clinical settings, offering numerous benefits for both patients and practitioners.

One of the primary advantages of disposable medical sensors is their convenience and hygiene. Unlike traditional reusable sensors that require extensive cleaning and sterilization after each use, disposable sensors are designed for single-use, eliminating the risk of cross-contamination and the transmission of infections between patients. This feature is particularly crucial in critical care environments such as intensive care units and operating rooms, where strict infection control measures are essential. Furthermore, disposable sensors are compact and lightweight, making them suitable for a wide range of applications, from continuous vital signs monitoring to specialized uses such as glucose monitoring or the detection of specific biomarkers. These sensors are designed to be user-friendly and typically require minimal training for healthcare professionals to use effectively.

Key Market Drivers

Rising Chronic Diseases and Aging Population

The prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and respiratory disorders, is on the rise globally. Additionally, the world's population is aging, leading to an increased demand for healthcare services. Disposable medical sensors play a crucial role in the management and early detection of these chronic conditions. For instance, disposable glucose sensors have revolutionized diabetes management by providing continuous and painless glucose monitoring, enhancing patient compliance, and reducing the risk of complications. One of the most notable contributions of disposable sensors in managing chronic diseases is in diabetes care. Diabetes, a metabolic disorder characterized by elevated blood sugar levels, affects millions of people globally. Continuous monitoring of blood glucose levels is paramount for effective diabetes management. Disposable glucose sensors have revolutionized this aspect of care by providing patients with a painless and convenient way to monitor their glucose levels continuously. These sensors eliminate the need for frequent fingerstick measurements, offering real-time data that empowers patients to make informed decisions about their diet, exercise, and medication.

Cardiovascular diseases, including heart attacks and strokes, are another major concern in the realm of chronic illnesses. Disposable sensors play a crucial role in early detection and monitoring of cardiac conditions. For instance, troponin sensors are used to measure cardiac biomarkers in blood samples, aiding in the rapid diagnosis of heart attacks. Such timely intervention is critical for minimizing heart damage and improving patient outcomes. Respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and asthma, benefit from disposable sensors that monitor oxygen saturation levels and airflow. These sensors enable healthcare providers to assess lung function and adjust treatment plans accordingly. They are particularly valuable during exacerbations or sudden worsening of symptoms. The aging global population adds another layer of complexity to the healthcare landscape. As people age, they become more susceptible to chronic diseases and may require ongoing medical attention. Disposable sensors address the unique needs of elderly patients by offering non-invasive and user-friendly solutions for continuous monitoring. They help healthcare providers detect age-related conditions early, manage chronic illnesses, and improve overall quality of life for older individuals.

Infection Control and Patient Safety

Infection control measures are paramount in healthcare settings to prevent healthcare-associated infections (HAIs). Disposable medical sensors mitigate the risk of cross-contamination, as they are used only once and then safely discarded. This not only enhances patient safety but also reduces the burden on healthcare facilities in terms of infection control protocols and associated costs. Disposable sensors, designed for single-use applications, offer a potent solution to mitigate the risk of cross-contamination, a primary avenue for HAIs. Unlike their reusable counterparts, which require extensive cleaning, sterilization, and maintenance, disposable sensors are used once and then safely discarded. This inherent disposability drastically reduces the chances of pathogen transmission between patients, healthcare professionals, and medical equipment.

One of the critical areas where infection control is of utmost importance is in the management of critical care patients. Intensive care units (ICUs) and operating rooms are high-risk environments where even a small lapse in infection control can have devastating consequences. Disposable medical sensors, integrated into vital monitoring equipment, provide a first line of defense against HAIs in these settings. They allow for continuous monitoring of essential parameters such as heart rate, blood pressure, and oxygen saturation, without the need for repeated sensor sterilization or disinfection. This not only enhances patient safety but also streamlines the workflow of healthcare professionals, ensuring that precious time is spent on patient care rather than infection control protocols. Patient safety, a cornerstone of healthcare, is not limited to infection control alone. It encompasses all aspects of care, including accurate and reliable monitoring. Disposable sensors contribute significantly to patient safety by providing healthcare professionals with accurate and real-time data.

Technological Advancements

Advances in sensor technology are a major driver of market growth. Miniaturization and the development of microelectromechanical systems (MEMS) have allowed for the creation of smaller, more precise sensors that can be integrated into various medical devices. Wireless connectivity and the Internet of Things (IoT) have enabled real-time data transmission, enabling remote patient monitoring and data analytics. Furthermore, the integration of artificial intelligence (AI) has the potential to enhance the capabilities of disposable sensors by providing predictive insights and decision support for healthcare professionals. Miniaturization has been a pivotal advancement in disposable sensor technology. The development of microelectromechanical systems (MEMS) has allowed for the creation of smaller, more precise sensors. These tiny sensors can be integrated into various medical devices, such as wearable fitness trackers, glucose meters, and diagnostic test strips. This miniaturization not only enhances the portability and ease of use of these devices but also reduces the cost of manufacturing, making them more accessible to healthcare providers and patients.

Wireless connectivity has played a pivotal role in the evolution of disposable medical sensors. The advent of the Internet of Things (IoT) has enabled real-time data transmission from these sensors to healthcare providers and electronic health record systems. This connectivity allows for remote monitoring of patients, enabling healthcare professionals to access critical data even when the patient is not physically present in a healthcare facility. For example, wearable devices equipped with disposable sensors can transmit vital signs, such as heart rate and oxygen saturation, to healthcare providers, ensuring that any alarming changes are detected and addressed promptly. The integration of AI with disposable sensors also has the potential to revolutionize disease management. Patients with chronic conditions can benefit from personalized treatment plans based on their sensor data and health history

Point-of-Care Testing (POCT)

The demand for rapid and accurate diagnostic tests at the point of care is growing rapidly. Disposable sensors are a critical component of POCT devices, allowing for quick and reliable testing without the need for complex laboratory infrastructure. This trend is particularly relevant in emergency care, remote or underserved areas, and for routine monitoring of chronic conditions. POCT represents a paradigm shift in healthcare, moving away from the traditional centralized laboratory model to decentralized, patient-centric testing. One of the primary benefits of POCT is the speed at which diagnostic results are obtained. Traditional lab testing often involves sending samples to off-site facilities, leading to delays in diagnosis and treatment. Disposable sensors, integrated into POCT devices, enable real-time or near-real-time testing, allowing healthcare providers to make immediate clinical decisions. This is especially critical in emergency situations, where quick diagnoses can be lifesaving.

POCT brings diagnostic testing closer to the patient, making healthcare services more accessible, particularly in remote or underserved areas. Disposable medical sensors are an integral component of these portable devices, which can be deployed in clinics, community health centers, ambulances, and even patients' homes. This democratization of diagnostics ensures that individuals have timely access to essential testing, improving healthcare equity. POCT devices are designed to be user-friendly, often requiring minimal training for healthcare professionals to operate effectively. Disposable sensors further simplify the testing process. Patients and caregivers can use these sensors without the need for specialized knowledge or complex sample collection procedures. This ease of use enhances patient engagement and compliance with testing protocols.

Key Market Challenges

Cost Considerations

While disposable sensors offer numerous advantages, they can be costlier in the long run compared to reusable sensors. The initial investment in disposable sensors and the ongoing need for replacements can strain healthcare budgets. Hospitals and healthcare facilities often face financial constraints, and the perceived higher cost of disposable sensors may deter their widespread adoption.

Cost-effectiveness has always been a critical factor in the healthcare industry, and disposable medical sensors are no exception. While these sensors offer numerous benefits, including reduced infection risk and improved patient comfort, their production cost remains relatively high. This cost is driven by the need for precision manufacturing, high-quality materials, and compliance with stringent quality control standards. Cost constraints can limit the adoption of disposable medical sensors, particularly in resource-constrained healthcare settings. Health systems, hospitals, and clinics may be hesitant to invest in these sensors due to budget constraints, even if they recognize the long-term advantages. Manufacturers must strike a delicate balance between cost and quality to remain competitive in this challenging market.

Data Security and Privacy

As disposable medical sensors become more connected and data-driven, concerns about data security and patient privacy have grown. These sensors collect and transmit sensitive patient data, including vital signs and health metrics, raising the risk of data breaches and unauthorized access. Healthcare organizations and manufacturers must invest heavily in robust data security measures to protect patient information. Additionally, there is an ongoing debate about data ownership and consent. Patients may be wary of using disposable sensors if they feel their data is being exploited without their consent. Striking a balance between the need for data to improve patient care and respecting patient privacy is a complex challenge that the market must address.

Regulatory Hinderences

The disposable medical sensors market, characterized by its potential to revolutionize healthcare monitoring, faces a formidable obstacle in the form of regulatory hurdles. These stringent regulatory frameworks, while essential for ensuring patient safety and product efficacy, often pose significant challenges for manufacturers and healthcare institutions alike. One of the primary challenges stems from the complex and time-consuming approval processes that disposable medical sensors must undergo in various regions. In the United States, for instance, the FDA's clearance process demands exhaustive documentation, rigorous testing, and meticulous attention to detail. These requirements, while vital for patient safety, can prolong the time it takes for manufacturers to bring their products to market. This delay not only increases operational costs but also hinders the timely availability of innovative sensor technologies to healthcare providers and patients. Moreover, the global landscape of regulatory standards and requirements is far from uniform. The diversity in regulations, which includes the FDA's requirements in the U.S., CE marking in Europe, and an array of national regulations in other countries, introduces complexity and variability for manufacturers. Adhering to different sets of rules and undergoing multiple approval processes adds layers of intricacy to market entry and expansion strategies.

Key Market Trends

Remote Patient Monitoring

The rise of remote patient monitoring is another significant trend boosting the disposable medical sensors market. In an era marked by the increasing importance of telemedicine and home-based care, disposable sensors are instrumental in enabling healthcare providers to remotely monitor patients' health. Remote patient monitoring not only enhances patient comfort but also allows for early detection of health issues and improved disease management. For instance, patients with chronic conditions like diabetes can benefit from continuous glucose monitoring using disposable sensors. These sensors transmit data to healthcare providers, who can make timely interventions and adjustments to treatment plans. The COVID-19 pandemic accelerated the adoption of remote patient monitoring, as it reduced the need for in-person visits and minimized the risk of infection transmission. This trend is expected to continue as healthcare systems recognize the cost-effectiveness and convenience of remote monitoring enabled by disposable sensors.

Expanding Applications

The versatility of disposable medical sensors is expanding their applications across various healthcare domains. Originally, these sensors were predominantly used in critical care settings, such as intensive care units and operating rooms. However, they are now being utilized in a wider range of clinical scenarios. One notable application is in sports and fitness monitoring. Athletes and fitness enthusiasts can wear disposable sensors to track their performance, heart rate, and other vital signs during exercise. These sensors provide valuable insights for optimizing training routines and preventing overexertion. Furthermore, disposable sensors are increasingly being integrated into home healthcare devices. Patients can now use disposable sensors with home-based medical equipment, such as blood pressure monitors and pulse oximeters, to collect data that can be shared with their healthcare providers. Furthermore, the adaptability of disposable medical sensors is evident in their growing presence in home healthcare settings. Patients can now use these sensors in conjunction with home-based medical equipment, such as blood pressure monitors and pulse oximeters.

Personalized Medicine

The trend toward personalized medicine, driven by advancements in genomics and data analytics, is also boosting the disposable medical sensors market. Personalized medicine aims to tailor healthcare interventions to an individual's unique genetic makeup, lifestyle, and health history. Disposable sensors are integral to this approach, as they enable the collection of real-time, personalized health data.For example, patients with chronic diseases can use disposable sensors to track their symptoms and response to treatment. This data can be integrated into personalized treatment plans, ensuring that patients receive the most effective and tailored care. For patients with chronic diseases, such as diabetes or hypertension, disposable sensors are indispensable. By monitoring vital signs and biomarkers in real time, healthcare providers can make data-driven decisions about treatment adjustments, lifestyle recommendations, and intervention timings. This personalized approach not only optimizes treatment outcomes but also enhances patient engagement and satisfaction.

Segmental Insights

Application Insights

Based on the application, the diagnostic segment emerged as the dominant player in the global Disposable Medical Sensors Market in 2022. This remarkable growth can be attributed to several factors including rising demand for point-of-care testing, technological advancements, chronic disease management, remote patient monitoring, etc. Disposable medical sensors play a critical role in POCT devices, allowing for rapid and accurate diagnostic tests in various healthcare settings. This trend has gained momentum, especially during the COVID-19 pandemic, where quick and reliable diagnostic tests have been of paramount importance.

Product Insights

Based on the product, the biosensors segment emerged as the dominant player in the global market for Disposable Medical Sensors in 2022. This is attributed to multiple factors including high sensitivity and specificity, real-time monitoring and diverse applications of biosensors. Biosensors are known for their exceptional sensitivity and specificity in detecting specific biomarkers and analytes. This attribute makes them invaluable in various medical applications, particularly in diagnosing diseases and monitoring patient health.

Regional Insights

North America emerged as the dominant player in the global Disposable Medical Sensors market in 2022, holding the largest market share. This is on account of its advanced healthcare infrastructure, strong adoption of technology, and robust research and development activities. North America consistently allocates a significant portion of its GDP to healthcare. This substantial healthcare expenditure allows for greater investment in medical technologies and the adoption of innovative solutions, including disposable sensors. Additionally, The prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and respiratory disorders, is on the rise in North America.

Key Market Players

SSI Electronics

ACE Medical Devices

Sensirion AG Switzerland

Smiths Medical

Koninklijke Philips N.V.

GE Healthcare

Analog Devices, Inc.

Honeywell International Inc

TE Connectivity

Medtronic PLC

Report Scope:

In this report, the Global Disposable Medical Sensors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
  • Disposable Medical Sensors Market, By Application:
  • Diagnostic
  • Therapeutic
  • Patient Monitoring
  • Disposable Medical Sensors Market, By Product:
  • Biosensors
  • Pressure Sensors
  • Accelerometer Sensors
  • Temperature Sensors
  • Image Sensors
  • Others
  • Disposable Medical Sensors Market, By Type:
  • Strip Sensor
  • Wearable Sensor
  • Implantable Sensor
  • Invasive Sensor
  • Ingestible Sensor
  • Disposable Medical Sensors Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Disposable Medical Sensors Market.

Company Information
  • Detailed analysis and profiling of additional market players (up to five).
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights


1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Impact of COVID-19 on Global Dermatological Therapeutics Market
5. Voice of Customer
6. Global Dermatological Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications)
6.2.2. By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, and Other Drug Classes)
6.2.3. By Region
6.2.4. By Company (2022)
6.3. Market Map
7. Asia Pacific Dermatological Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By Drug Class
7.2.3. By Country
7.3. Asia Pacific: Country Analysis
7.3.1. China Dermatological Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Drug Class
7.3.2. India Dermatological Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Drug Class
7.3.3. Australia Dermatological Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Drug Class
7.3.4. Japan Dermatological Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Application
7.3.4.2.2. By Drug Class
7.3.5. South Korea Dermatological Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Application
7.3.5.2.2. By Drug Class
8. Europe Dermatological Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By Drug Class
8.2.3. By Country
8.3. Europe: Country Analysis
8.3.1. France Dermatological Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Drug Class
8.3.2. Germany Dermatological Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Drug Class
8.3.3. Spain Dermatological Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Drug Class
8.3.4. Italy Dermatological Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Drug Class
8.3.5. United Kingdom Dermatological Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Drug Class
9. North America Dermatological Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By Drug Class
9.2.3. By Country
9.3. North America: Country Analysis
9.3.1. United States Dermatological Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Drug Class
9.3.2. Mexico Dermatological Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Drug Class
9.3.3. Canada Dermatological Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Drug Class
10. South America Dermatological Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Drug Class
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Dermatological Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Drug Class
10.3.2. Argentina Dermatological Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Drug Class
10.3.3. Colombia Dermatological Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Drug Class
11. Middle East and Africa Dermatological Therapeutics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Application
11.2.2. By Drug Class
11.2.3. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Dermatological Therapeutics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Application
11.3.1.2.2. By Drug Class
11.3.2. Saudi Arabia Dermatological Therapeutics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Application
11.3.2.2.2. By Drug Class
11.3.3. UAE Dermatological Therapeutics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Application
11.3.3.2.2. By Drug Class
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Recent Developments
13.2. Product Launches
13.3. Mergers & Acquisitions
14. Global Dermatological Therapeutics Market: SWOT Analysis
15. Porter’s Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Product
16. PESTLE Analysis
17. Competitive Landscape
17.1. Business Overview
17.2. Company Snapshot
17.3. Products & Services
17.4. Financials (In case of listed companies)
17.5. Recent Developments
17.6. SWOT Analysis
17.6.1. Abbvie Inc. (Allergan PLC)
17.6.2. Almirall SA
17.6.3. Amgen Inc.
17.6.4. Bausch Health Companies Inc.
17.6.5. Galderma SA
17.6.6. GlaxoSmithKline PLC
17.6.7. Johnson & Johnson
17.6.8. Novartis AG
17.6.9. Pfizer Inc.
17.6.10. Bristol-Myers Squibb Company
18. Strategic Recommendations
19. About Us & Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings